Kyowa Company Ltd.

International Private company
Ohtemachi Bldg.,1-6-1 Ohtemachi, Chiyoda-ku,, Tokyo,  100-8185, Japan
()332820007, 332841968 fax, http://www.kyowa.co.jp

Primary SIC: Medical Chemicals & Botanical Products, Primary NAICS: Medicinal and Botanical Manufacturing
Description: Manufacturing: Manufacture and sale of ethical drugs and diagnostic reagents

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Kyowa Company Ltd., News and Information

Dicerna Signs Research Collaboration and License Agreement for Drug Delivery Systems and Dicer Substrate siRNA (DsiRNA) Pharmaceuticals with Kyowa Hakko Kirin.
Business Wire; 1/4/2010; 1450 words; ...interference (RNAi) company developing novel...molecules, and Kyowa Hakko Kirin Co., Ltd. (TSE: 4151) (Kyowa Hakko Kirin...biopharmaceutical companies, announced today...Pharma Co., Ltd., with the...pharmaceutical company that creates...To that end, Kyowa Hakko Kirin ...

AVEO Files $86M IPO to Support New Phase III Kidney Cancer Trial.
BIOWORLD Today; 12/18/2009; 1290 words; ...Three U.S. drug companies have priced IPOs so...in the wings. Drug companies with IPO paperwork currently...Pharmaceuticals Inc., antibiotic company Trius Therapeutics Inc...Inc., cardiovascular company Anthera Pharmaceuticals...tivozanib from Tokyo-based Kyowa Hakko Kirin Co. Ltd. ...

Research and Markets Adds Report: Eisai: Pipeline, Products, Performance and Potential.(Company overview)
Health & Beauty Close-Up; 12/9/2009; 1020 words; ...future. A section on company strategy covers mergers...comprehensive review of the company's product portfolio...as the larger pharma companies from Europe and the...Mitsubishi Tanabe Pharma and Kyowa Hakko Kirin). Eisai...fiscal 2006), and the company continues to strive...Pharmatechnology ...

BRIEFING - ASIA HEALTH - DEC 8, 2009.
AsiaPulse News; 12/8/2009; 1559 words; ...Vietnam Pharmaceutical Companies Association (VPCA...Japanese pharmaceutical companies increasingly seeking...BUY AQUACULTURE OPS OF KYOWA HAKKO KIRIN UNIT TOKYO...that it will purchase Kyowa Hakko Bio Co.'s domestic...based drug developer CBio Ltd has extended its initial...

Foreign Subsidiaries and Operations Generated 57.5 Per Cent of Eisai's Sales in Fiscal 2009 (Compared to 52.6 Per Cent in Fiscal 2006).
M2 Presswire; 12/2/2009; 1242 words; ...future. A section on company strategy covers mergers...comprehensive review of the company's product portfolio...as the larger pharma companies from Europe and the...Mitsubishi Tanabe Pharma and Kyowa Hakko Kirin). Eisai...fiscal 2006), and the company continues to strive...Pharmatechnology ...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.